Receptor

Edit

Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist

Hastings Tribune 29 Jun 2026

The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain ... .

Edit

Story Time with Reavis: Taste receptors change as the years pass

The Paris News 28 Jun 2026

‘This Dr Pepper doesn’t taste right.” ....

Edit

IIT-K team solves mystery of atypical drug target receptor

The Times of India 25 Jun 2026

Comments. +Text SizeSmallMediumLarge. .

Edit

Drug peptides defy shape rules, activating receptors without full spiral form

Phys Dot Org 24 Jun 2026

Most of the information is contained in molecules that engage with receptor proteins on cell surfaces ... transfer at specific receptor proteins.

Edit

A receptor-like mechanosensitive protein governs preprophase band positioning for asymmetric cell divisions and SC morphogenesis

PNAS 24 Jun 2026

.

Edit

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) (Form 8-K) (Absci Corporation)

Public Technologies 24 Jun 2026

) Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) ... investigational anti-prolactin receptor (PRLR) antibody.

Edit

Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults

PR Newswire 24 Jun 2026

"Therapies that target amylin and calcitonin receptors may potentially be used alone or in combination with GLP-1 or dual GLP-1/GIP agonists to improve the induction of weight loss as well as for longer-term weight management.

Edit

A receptor kinase complex refines cambium activity in Arabidopsis

PNAS 22 Jun 2026

The central component of this ... .

Edit

Insomnia Market Witnesses Robust Growth During the Forecast Period (2026-2036) with Emerging Orexin Receptor Antagonists and Melatonin Receptor Agonist | DelveInsight

PR Newswire 18 Jun 2026

Novel orexin receptor antagonists and digital therapeutics are reshaping the competitive landscape ... These comprise the newer orexin receptor antagonists, benzodiazepines, non-benzodiazepine agents, as well as melatonin receptor agonists.

Edit

FcRL4 is an IgA receptor that primarily binds the joining chain

PNAS 17 Jun 2026

... A (IgA) receptor, selectively recognizes specific IgA forms.

Edit

GLP-1 Receptor Agonists Market Gains Momentum as Weight-Loss Drugs Redefine Diabetes and Heart Care - Says Strategic Market Research

PR Newswire 17 Jun 2026

Global GLP-1 Receptor Agonists Market to grow from USD 18.4 billion in 2024 to USD 41.5 billion by 2030 as diabetes treatment, obesity care, cardiovascular risk reduction, oral drug innovation, and payer access reshape metabolic therapeutics.

Edit

MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy

ACCESSWIRE 17 Jun 2026

Food and Drug Administration (FDA) for Ketamir-2, the Company's proprietary oral NMDA receptor modulator, in chemotherapy-induced peripheral neuropathy (CIPN) ... Ketamir-2 is an oral NMDA receptor modulator in development for chronic neuropathic pain.

Edit

[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a ...

Nasdaq Globe Newswire 16 Jun 2026

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at ...

Edit

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological ...

Nasdaq Globe Newswire 15 Jun 2026

ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a ...

Edit

Endothelial c-IAP2 loss amplifies P2X7 receptor-driven inflammation and worsens schistosomiasis-associated pulmonary hypertension

PNAS 15 Jun 2026

Moreover, CDC reports indicate >... .

Podcasts:

Latest News for: receptor

Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist

Story Time with Reavis: Taste receptors change as the years pass

IIT-K team solves mystery of atypical drug target receptor

Drug peptides defy shape rules, activating receptors without full spiral form

A receptor-like mechanosensitive protein governs preprophase band positioning for asymmetric cell divisions and SC morphogenesis

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) (Form 8-K) (Absci Corporation)

Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults

A receptor kinase complex refines cambium activity in Arabidopsis

Insomnia Market Witnesses Robust Growth During the Forecast Period (2026-2036) with Emerging Orexin Receptor Antagonists and Melatonin Receptor Agonist | DelveInsight

FcRL4 is an IgA receptor that primarily binds the joining chain

GLP-1 Receptor Agonists Market Gains Momentum as Weight-Loss Drugs Redefine Diabetes and Heart Care - Says Strategic Market Research

MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy

[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a ...

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological ...

Endothelial c-IAP2 loss amplifies P2X7 receptor-driven inflammation and worsens schistosomiasis-associated pulmonary hypertension

Article Search

EXPLORE WN.com